IJMS | Free Full-Text | Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Erivedge (vismodegib) – Treatment for Advanced Basal Cell Carcinoma - Clinical Trials Arena
Figure 1 from Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas. | Semantic Scholar
Mechanistic Insights into the Generation and Transduction of Hedgehog Signaling: Trends in Biochemical Sciences
Vismodegib | C19H14Cl2N2O3S | CID 24776445 - PubChem
Frontiers | Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
Erivedge (vismodegib) – Treatment for Advanced Basal Cell Carcinoma - Clinical Trials Arena
View of Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma | Acta Dermato-Venereologica
Cells | Free Full-Text | Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
Vismodegib and the Hedgehog Pathway: A New Treatment for Basal Cell Carcinoma - ScienceDirect
Vismodegib
Hedgehog Signaling Pathway Inhibitors for Basal Cell Carcinoma | SpringerLink
Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma
Vismodegib: a promising drug in the treatment of basal cell carcinomas | Future Oncology
Repurposing itraconazole for the treatment of cancer (Review)
Cells control energy metabolism via hedgehog signalling pathway | Max-Planck-Gesellschaft
Vismodegib: A Review - ScienceDirect
Altered Hh signalling pathway and mechanism of action of vismodegib and... | Download Scientific Diagram
IJMS | Free Full-Text | Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Vismodegib | Nature Reviews Drug Discovery
Cholesterol access in cellular membranes controls Hedgehog signaling | Nature Chemical Biology
Sonic Hedgehog pathway in the pathogenesis of basal cell carcinoma. | Download Scientific Diagram
Targeting the Hedgehog Pathway Holds Promises and Pitfalls
Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis | Acta Neuropathologica Communications | Full Text
Vismodegib - Wikipedia
Frontiers | The hedgehog pathway in hematopoiesis and hematological malignancy
Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms | PLOS ONE
